 |
|
| There is often a mismatch between population demographics and participants in clinical trials. This can have a dire impact as the results of a trial may not be broadly applicable to all affected by the disease. Time, money and opportunity are lost. The ongoing coronavirus pandemic further highlights this challenge. Many of the critically-ill patients are from ethnic minority backgrounds, and may not be participating in clinical trials at that same rate. This interactive webinar featuring an esteemed panel of presenters defines diversity in clinical trials showcasing the regional, gender and socio-economic differences that impact representation in clinical trials. Together, the panellists encourage participants to make a difference in their communities and companies, finding ways to build trust and make clinical trials more inclusive. |